Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tacedinaline (CI994) 是一种组蛋白脱乙酰酶抑制剂,抑制重组 HDAC 1, 2 和 3 的IC50值分别为 0.9,0.9,1.2 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 198 | 现货 | ||
10 mg | ¥ 328 | 现货 | ||
25 mg | ¥ 587 | 现货 | ||
50 mg | ¥ 997 | 现货 | ||
100 mg | ¥ 1,660 | 现货 | ||
200 mg | ¥ 2,810 | 现货 | ||
500 mg | ¥ 4,680 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 363 | 现货 |
产品描述 | Tacedinaline (CI994) is a selective class I HDAC inhibitor with potential antineoplastic activity. |
靶点活性 | HDAC1:0.9 μM, HDAC3:1.2 μM, HDAC2:0.9 μM |
体外活性 | 在耐化疗的胰腺导管癌小鼠,和人前列腺肿瘤模型中,CI-994均表现出抗肿瘤活性. |
体内活性 | CI-994具有抗肿瘤活性,并且在实体肿瘤中表现出更高的细胞毒作用。在多种细胞中,CI-994抑制细胞生长,如大鼠白血病BCLO细胞(IC50=2.5 μM),LNCaP细胞(IC50=7.4 μM)。在A-549和LX-1细胞中,CI-994(< 160 mM )使细胞在G0/G1期增加,S期减少,能够抑制细胞生长,并且诱导细胞凋亡。 |
细胞实验 | LNCaP cell lines are maintained in RPMI 1640 medium containing 10% fetal bovine serum, 1% penicillin and streptomycin, as the complete culture medium. Cells (2×104) are seeded in 24-well plates and incubated in a 5% CO2 incubator at 37 °C for 1 day. Cultures are treated with CI-994, alone and in combination on day 2 and 4. Cells are washed on day 2 and 4 and media are changed. Mitochondrial metabolism is measured as a marker for cell growth by adding 100 μL/well MTT (5 mg/mL in medium) with 2 hours incubation at 37 °C on Day 6. Crystals formed are dissolved in 500 μL of DMSO. The absorbance is determined using a microplate reader at 560 nm. The absorbance data are converted into cell proliferation percentage. Each assay is performed in triplicate. (Only for Reference) |
别名 | Acetyldinaline, N-acetyldinaline, PD-123654, CI994, Goe-5549 |
分子量 | 269.3 |
分子式 | C15H15N3O2 |
CAS No. | 112522-64-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 26.9 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.7133 mL | 18.5667 mL | 37.1333 mL | 92.8333 mL |
5 mM | 0.7427 mL | 3.7133 mL | 7.4267 mL | 18.5667 mL | |
10 mM | 0.3713 mL | 1.8567 mL | 3.7133 mL | 9.2833 mL | |
20 mM | 0.1857 mL | 0.9283 mL | 1.8567 mL | 4.6417 mL | |
50 mM | 0.0743 mL | 0.3713 mL | 0.7427 mL | 1.8567 mL | |
100 mM | 0.0371 mL | 0.1857 mL | 0.3713 mL | 0.9283 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Tacedinaline 112522-64-2 Apoptosis Chromatin/Epigenetic DNA Damage/DNA Repair HDAC PD 123654 Goe5549 Acetyldinaline CI-994 CI 994 N-acetyldinaline inhibit PD-123654 Inhibitor Histone deacetylases CI994 Goe 5549 Goe-5549 PD123654 inhibitor